Source: VC News Daily

Wellington Management: Atsena Therapeutics Inks $150M Series C Financing

DURHAM, NC, Atsena Therapeutics, a clinical-stage gene therapy company, announced the successful close of an oversubscribed $150 million Series C financing.

Read full article »
Est. Annual Revenue
$1.0-5.0B
Est. Employees
500-1.0K
Jean Hynes's photo - CEO of Wellington Management

CEO

Jean Hynes

CEO Approval Rating

49/100

Read more